Leishmania major infection in susceptible and resistant mice elicit a differential humoral response against a total soluble fraction and defined recombinant antigens of the parasite

Parasitology Research

Volumn 102, Issue 5, 2008, Pages 887-893

  Iniesta, Virginia ^a   Corraliza, Inés ^a   Carcelén, Jesualdo ^a   Gómez Gordo, Luis ^a   Fernández Cotrina, Javier ^a   Parejo, Juan Carlos ^a   Carrión, Javier ^b   Soto, Manuel ^b   Alonso, Carlos ^b   Gómez Nieto, Carlos ^a  

^a UNIVERSITY OF EXTREMADURA   (Spain)

^b CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOPLASM PROTEIN; KINETOPLASTIC MEMBRANE PROTEIN 11; MEMBRANE PROTEIN; PARASITE ANTIGEN; PQ PROTEIN; PROTOZOON ANTIBODY; RECOMBINANT ANTIGEN; SOLUBLE LEISHMANIA ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN RECOGNITION; ARTICLE; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEVELOPMENTAL STAGE; DISEASE COURSE; EXPERIMENTAL INFECTION; GENE FUSION; HISTOPATHOLOGY; HUMORAL IMMUNITY; IMMUNE RESPONSE; INFECTION RESISTANCE; INFECTION SENSITIVITY; KINETOPLAST; LEISHMANIA MAJOR; LEISHMANIASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

LEISHMANIA MAJOR; MUS;

EID: 41549149610     PISSN: 09320113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00436-007-0844-9     Document Type: Article

References (30)

1. Andrade ZA, Reed ST, Roters SB, Sadigursky M (1984) Patogenia da leishmaniose cutânea experimental a importância da necrose na eliminaçâo dos parasitos das lesǒes. Rev Soc Bras Med Trop 17:187-197
2. Beil WJ, Meinardus-Hager G, Neugebauer DC, Sorg C (1992) Differences in the onset of the inflammatory response to cutaneous leishmaniasis in resistant and susceptible mice. J Leukoc Biol 52:135-142
3. Berberich C, Requena JM, Alonso C (1997) Cloning of genes and expression and antigenicity analysis of the Leishmania infantum KMP11 protein. Exp Parasitol 85(1):105-108
4. Chang KP, Reed SG, McGwire BS, Soong L (2003) Leishmania model for microbial virulence: the relevance of parasite multiplication and pathoantigenicity. Acta Trop 85(3):375-390
5. De Carvalho LP, Soto M, Jeronimo S, Dondji B, Bacellar O, Luz V, Orge Orge G, Alonso C, Jesus AR, Carvalho EM (2003) Characterization of the immune response to Leishmania infantum recombinant antigens. Microbes Infect 5(1):7-12
6. Deplazes P, Smith NC, Arnold P, Lutz H, Eckert J (1995) Specific IgG1 and IgG2 antibody responses of dogs to Leishmania infantum and other parasites. Parasite Immunol 17(9):451-458
7. Ghose AC, Haldar JP, Pal SC, Mishra BP, Mishra KK (1980) Serological investigations of Indian kala-azar. Clin Exp Immunol 40(2):318-326
8. Gonzalo RM, Rodríguez JR, Rodríguez D, González- Aseguinolaza G, Larraga V, Esteban M (2001) Protective immune response against cutaneous leishmaniasis by prime/booster immunization regimens with vaccinia virus recombinants expressing Leishmania infantum p36/LACK and IL-12 in combination with purified p36. Microbes Infect 3(9):701-710
9. Heinzel FP, Sadick MD, Mutha SS, Locksley RM (1991) Production of interferon gamma, interleukin-2, interleukin-4 and interleukin-10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis. Proc Natl Acad Sci U S A 88(16):7011-7015
10. Howard MK (1985) Host immunity to leishmaniasis. In: Bray RS, Chang KP (eds) Human parasitic diseases, vol. I: leishmaniasis. Elsevier, Amsterdam, pp 139-162
11. Iniesta V, Carcelén J, Molano I, Peixoto PMV, Redondo E, Parra P, Mangas M, Monroy M, Gómez Nieto C, Corraliza I (2005) Arginase I induction during Leishmania major infection is mediating the development of the disease. Infect Immun 73(9):6085-6090
12. Joshi PB, Kelly BL, Kamhawi S, Sacks DL, McMaster WR (2002) Targeted gene deletion in Leishmania major identifies leishmanolysin (GP63) as a virulence factor. Mol Biochem Parasitol 120:33-40
13. Liew FY, O'Donnell CA (1993) Immunology of leishmaniasis. Adv Parasitol 32:161-259
14. Locksley RM, Heinzel FP, Holaday BJ, Mutha SS, Reiner SL, Sadick MD (1991) Induction of Th1 and Th2 CD4+ subsets during murine Leishmania major infection. Res Immunol 142(1):28-32
15. Molano I, Alonso MG, Mirón C, Redondo E, Requena JM, Soto M, Gómez Nieto C, Alonso C (2003) A Leishmania infantum multi-component antigenic protein mixed with live BCG confers protection to dogs experimentally infected with L. infantum. Vet Immunol Immunopathol 92(1-2):1-13
16. Monroy A, Ridley DS, Heather CJ, Ridley MJ (1980) Histological studies of the elimination of Leishmania enriettii from skin lesions in the guinea-pig. Br J Exp Pathol 61(6):601-610
17. Morsy TA, El-Okby LM, Helmy OM, Makrm SS, Essa MH (1987) The class of immunoglobulins versus the histological picture in cutaneous leishmaniasis. J Egypt Soc Parasitol 17(2):723-728
18. Nieto CG, García-Alonso M, Requena JM, Mirón C, Soto M, Alonso C, Navarrete I (1999) Analysis of the humoral immune response against total and recombinant antigens of Leishmania infantum: correlation with disease progression in canine experimental leishmaniosis. Vet Immunol Immunopathol 67(2):117-130
19. Requena JM, Alonso C, Soto M (2000a) Evolutionarily conserved proteins as prominent immunogens during Leishmania infections. Parasitol Today 16(6):246-250
20. Requena JM, Soto M, Doria MD, Alonso C (2000b) Immune and clinical parameters associated with Leishmania infantum infection in the golden hamster model. Vet Immunol Immunopathol 76(3-4):269-281
21. Ridley MJ, Ridley DS (1984) Cutaneous leishmaniasis: immune complex formation and necrosis in the acute phase. Br J Exp Pathol 65(3):327-336
22. Sacks D, Noben-Trauth N (2002) The immunology of susceptibility and resistance to Leishmania major in mice. Nat Rev Immunol 2(11):845-858
23. Satoskar AR, Stamn LM, Zhang X, Satoskar AA, Okano M, Terhorst C, David JR, Wang B (1999) Mice lacking NK cells develop an efficient Th1 response and control cutaneous Leishmania major infection. J Immunol 162(11):6747-6754
24. Scott P, Natovitz P, Coffman RL, Pearce E, Sher A (1988) Immunoregulation of cutaneous leishmaniasis T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. J Exp Med 168(5):1675-1684
25. Solbach W, Asmuss PA, Zimmermann S, Humborg C, Rollinghoff M (1995) Protective effect of leflunomide on the natural course of Leishmania major-induced disease in genetically susceptible BALB/c mice. Int J Immunopharmacol 17(6):481-488
26. Soto M, Requena JM, Quijada L, Garcia M, Guzman F, Patarroyo ME, Alonso C (1995a) Mapping of the linear antigenic determinants from the Leishmania infantum histone H2A recognized by sera from dogs with leishmaniasis. Immunol Lett 48(3):209-214
27. Soto M, Requena JM, Quijada L, Angel SO, Gomez LC, Guzman F, Patarroyo ME, Alonso C (1995b) During active viscerocutaneous leishmaniasis the anti-P2 humoral response is specifically triggered by the parasite P proteins. Clin Exp Immunol 100(2):246-252
28. Soto M, Requena JM, Quijada L, Alonso C (1998) Multicomponent chimeric antigen for serodiagnosis of canine visceral leishmaniasis. J Clin Microbiol 36(1):58-63
29. Spath GF, Epstein L, Leader B, Singer SM, Avila HA, Turco SJ, Beverley SM (2000) Lipophosphoglycan is a virulence factor distinct from related glycoconjugates in the protozoan parasite Leishmania major. Proc Natl Acad Sci U S A 97(16):9258-9263
30. Stacey KJ, Blackwell J (1999) Immunostimulatory DNA as an adjuvant in vaccination against Leishmania major. Infect Immun 67(8):3719-3726